Pathophysiology and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathies

Area of Science:

• Neuroimmunology
• Neurology
• Pathophysiology

Background:

• Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired autoimmune disorder with diverse clinical presentations, prognoses, and treatment responses.
• Despite advances, the precise pathophysiology and target antigens in CIDP remain incompletely understood.
• Key factors implicated include cell-mediated immunity, blood-nerve barrier disruption, impaired T-cell regulation, and nodal/paranodal organization damage.

Purpose of the Study:

• To provide a comprehensive overview of the primary pathophysiological mechanisms underlying CIDP.
• To review the identified biomarkers associated with CIDP.
• To consolidate current knowledge on CIDP pathogenesis for improved clinical understanding.

Main Methods:

• Literature review of recent research on CIDP pathophysiology.
• Analysis of studies investigating immune cell involvement (T lymphocytes, macrophages).
• Examination of research on blood-nerve barrier integrity and nodal/paranodal disruptions.

Main Results:

• CIDP pathophysiology involves complex interactions including cell-mediated immunity and blood-nerve barrier breakdown.
• Autoantibodies against axoglial adhesion molecules may disrupt ion channel clustering, impairing nerve conduction.
• Disruption of nodal and paranodal organization contributes significantly to CIDP's clinical manifestations.

Conclusions:

• Understanding the multifaceted pathophysiological mechanisms of CIDP is essential for therapeutic development.
• Identification of specific biomarkers is critical for diagnosis, prognosis, and targeted treatments in CIDP.
• Further research into autoantibodies and immune dysregulation holds promise for advancing CIDP management.